| Title |
Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2014
|
| DOI | 10.1002/14651858.cd010018.pub2 |
| Pubmed ID | |
| Authors |
Sven M Schulzke, Siree Kaempfen, Sanjay K Patole |
| Abstract |
Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants. BPD is associated with poor long-term respiratory and neurodevelopmental outcome and increased mortality. The prophylactic use of agents that modulate inflammation such as pentoxifylline, a synthetic methylxanthine and phosphodiesterase inhibitor, may reduce the incidence of BPD. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Unknown | 160 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 13% |
| Student > Bachelor | 21 | 13% |
| Researcher | 19 | 12% |
| Student > Ph. D. Student | 17 | 11% |
| Student > Doctoral Student | 10 | 6% |
| Other | 29 | 18% |
| Unknown | 44 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 58 | 36% |
| Nursing and Health Professions | 21 | 13% |
| Psychology | 8 | 5% |
| Social Sciences | 6 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 18 | 11% |
| Unknown | 45 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2014.
All research outputs
#15,311,799
of 22,772,779 outputs
Outputs from Cochrane database of systematic reviews
#10,778
of 12,314 outputs
Outputs of similar age
#214,267
of 361,959 outputs
Outputs of similar age from Cochrane database of systematic reviews
#239
of 270 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,959 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 270 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.